MedTrace Logo

Validation of Gene Expression Markers of Renal Allograft Functional Decline

NCT01782586 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 499

Last updated 2019-10-04

No results posted yet for this study

Summary

The purpose of this study is to determine if certain genes found in a kidney biopsy performed at one-year post transplant can predict which transplanted kidneys will have decreased kidney function within five years post-transplant.

Conditions

  • Kidney Transplant Recipients

Sponsors & Collaborators

  • Genomics of Transplantation Cooperative Research Program

    collaborator UNKNOWN

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Mark D. Stegall, MD · Mayo Clinic, Rochester, MN

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01782586 on ClinicalTrials.gov